Sept. 4, 2020
BAMC, WHASC chosen for COVID-19 vaccine trials
WASHINGTON —
As part of the Operation Warp Speed, or OWS, goal to deliver safe and effective vaccines and therapeutics by January 2021, five Department of Defense locations have been identified to participate in the Phase III trial evaluating the vaccine candidate AZD1222 under development by AstraZeneca. Two of the locations are in San Antonio.